Barcelona Biotech Flavii Therapeutics Secures €843,000 Seed Funding for CNS Drug Development
Flavii Therapeutics, a Barcelona‑based university spin‑off, raised close to €1 million (€843,000) in a funding round led by Grow Venture Partners to fund the development of novel central nervous system treatments.